ArticleJournal of minimal access surgery2026
Residual cystic duct: An independent risk factor for post-cholecystectomy syndrome, with 287 cases.
Article in Journal of minimal access surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 syntheses or guidelines pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe objective is to investigate the relationship between post-operative cystic syndrome (PCS) and post-operative residual cystic duct. PATIENTS AND
methodsA retrospective analysis was performed on 287 patients diagnosed with cholecystolithiasis complicated with cystic inflammation who were admitted to the Second Affiliated Hospital of Kunming Medical University from August 2017 to September 2021. Residual cystic ducts >10 mm were included in the residual cystic duct group, and 5-10 mm were included in the non-residual cystic duct group. The two groups were compared for differences in cholecystitis, cholecystolithiasis, low confluence common bile duct, cystic duct dilation, duodenal papillary diverticulum, common bile duct calculus and ampullitis, and then, univariate and multivariate analyses were performed. Moreover, the characteristics of PCS cases in the residual cystic duct group and the non-residual cystic duct group and the differences in VAS pain index and duration of pain at different time points in post-operative follow-up.
resultsThe incidence of PCS was 21.73% in the residual cystic duct group and 9.23% in the non-residual cystic duct group ( P = 0.004). Overall, logistic multivariate analysis of 287 patients showed that cystic duct residue (OR = 2.308, 95% CI = 1.160-4.595, P = 0.017) was an independent risk factor for PCS.
conclusionResidual cystic duct (residual length of cystic duct >10 mm) is an independent risk factor for PCS. Compared with PCS without residual cystic duct, jaundice and abdominal pain are more serious and have no tendency to relieve. The probability of reoperation is high, which is worthy of attention in clinical diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.